Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Liver Regeneration01:24

Liver Regeneration

4.5K
The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
4.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CD11c<sup>+</sup> T-Bet<sup>+</sup> B Cell Expansion Reveals a Distinct Pathogenic Signature in Autoimmune Liver Diseases.

Liver international : official journal of the International Association for the Study of the Liver·2026
Same author

Ileal Bile Acid Transporter Inhibitors for Symptomatic Cholestasis due to Vanishing Bile Duct Syndrome in Adults.

ACG case reports journal·2026
Same author

Spatial proteomics and cell-cell cross-talk analysis reveal PD-L1 and IL-6 interaction in human primary sclerosing cholangitis.

JHEP reports : innovation in hepatology·2026
Same author

Integrating Advanced Endoscopic Techniques and Confocal Microscopy for Early Detection of Extrahepatic Cholangiocarcinoma.

Cancers·2026
Same author

Bile Acid Sequestrants in Primary Sclerosing Cholangitis and the Risk of Acute Cholangitis: Cause for Concern?

Clinical and translational gastroenterology·2026
Same author

Management of Liver Cirrhosis in Percutaneous and Surgical Cardiac Interventions.

Journal of the American Heart Association·2026

Related Experiment Video

Updated: Feb 26, 2026

Isolation of Neonatal Extrahepatic Cholangiocytes
07:54

Isolation of Neonatal Extrahepatic Cholangiocytes

Published on: June 5, 2014

10.9K

Cholangiocytes: Cell transplantation.

Lorenzo Ridola1, Maria Consiglia Bragazzi1, Vincenzo Cardinale1

  • 1Department of Medico-Surgical Sciences and Biotechnologies, Polo Pontino, Sapienza University of Rome, Italy.

Biochimica Et Biophysica Acta. Molecular Basis of Disease
|July 24, 2017
PubMed
Summary

Human biliary tree stem cells (hBTSCs) show promise as an ideal cell source for liver disease therapy, offering significant benefits without adverse events in initial cirrhotic patient trials.

Keywords:
Biliary tree stem cellsGraftingHepatic stem cellsHepatocytesLiver cell therapyMesenchymal stem cells

More Related Videos

Generation of a Humanized Mouse Liver Using Human Hepatic Stem Cells
11:44

Generation of a Humanized Mouse Liver Using Human Hepatic Stem Cells

Published on: August 29, 2016

11.5K
Intrasplenic Transplantation of Hepatocytes After Partial Hepatectomy in NOD.SCID Mice
11:24

Intrasplenic Transplantation of Hepatocytes After Partial Hepatectomy in NOD.SCID Mice

Published on: February 10, 2018

14.8K

Related Experiment Videos

Last Updated: Feb 26, 2026

Isolation of Neonatal Extrahepatic Cholangiocytes
07:54

Isolation of Neonatal Extrahepatic Cholangiocytes

Published on: June 5, 2014

10.9K
Generation of a Humanized Mouse Liver Using Human Hepatic Stem Cells
11:44

Generation of a Humanized Mouse Liver Using Human Hepatic Stem Cells

Published on: August 29, 2016

11.5K
Intrasplenic Transplantation of Hepatocytes After Partial Hepatectomy in NOD.SCID Mice
11:24

Intrasplenic Transplantation of Hepatocytes After Partial Hepatectomy in NOD.SCID Mice

Published on: February 10, 2018

14.8K

Area of Science:

  • Hepatology
  • Stem Cell Biology
  • Regenerative Medicine

Background:

  • Orthotropic liver transplantation faces access limitations, driving interest in cell therapies for liver diseases.
  • Existing cell therapies have limitations, including the need for immunosuppression with adult hepatocytes and limited efficacy of mesenchymal and hematopoietic stem cells.

Purpose of the Study:

  • To review current literature on cell therapy for liver diseases.
  • To evaluate the advantages and disadvantages of various cell sources used in clinical trials.
  • To explore the potential benefits of human biliary tree stem cells (hBTSCs) for liver disease treatment.

Main Methods:

  • Literature review of cell therapy for liver diseases.
  • Analysis of clinical trial data for different stem cell sources.
  • Identification and characterization of multipotent stem cells in human biliary and gallbladder tissues.

Main Results:

  • Adult hepatocyte transplantation provides transient benefits but requires immunosuppression.
  • Mesenchymal and hematopoietic stem cells modulate autoimmune/inflammatory processes rather than replacing hepatocytes.
  • Multipotent stem cells expressing endodermal markers were identified in human biliary tree and gallbladder epithelium.
  • Initial clinical trials using hBTSCs in cirrhotic patients showed no adverse events and significant benefits.

Conclusions:

  • Human biliary tree stem cells (hBTSCs) represent a promising and potentially ideal cell source for liver disease therapy.
  • hBTSCs demonstrated safety and efficacy in early-stage cirrhotic patient treatment.
  • Further research into hBTSCs could offer new therapeutic avenues for advanced liver diseases.